Open Access

RNA interference targeting Aurora-A sensitizes glioblastoma cells to temozolomide chemotherapy

  • Authors:
    • Jing Gan
    • Fangfang Wang
    • Dezhi Mu
    • Yi Qu
    • Rong Luo
    • Qiu Wang
  • View Affiliations

  • Published online on: October 14, 2016     https://doi.org/10.3892/ol.2016.5261
  • Pages: 4515-4523
  • Copyright: © Gan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Clinically, temozolomide (TMZ) is widely used in glioblastoma (GBM) treatment. However, the toxicity of TMZ may influence the quality of patient life. Thus, novel treatment options for sensitizing GBM cells to TMZ chemotherapy are necessary. Aurora‑A is widely expressed in GBM and correlated with poor prognosis. It has been proven to be an effective target for gene therapy and chemotherapy. In the present study, short hairpin (sh)RNA targeting Aurora‑A was employed to knockdown Aurora‑A expression in GBM cells. Cell Counting Kit‑8 assays, flow cytometry, colony formation assays, invasion assays and tube formation assays were used to determine the effects of Aurora‑A knockdown when combined with TMZ treatment. A U251 subcutaneous cancer model was established to evaluate the efficacy of combined therapy. The results of the present study indicated that the proliferation, colony formation, invasion and angiogenesis of GBM cells were significantly inhibited by combined therapy when compared with TMZ treatment alone. In vivo results demonstrated that knockdown of Aurora‑A significantly (P=0.0084) sensitizes GBM cells to TMZ chemotherapy. The results of the present study demonstrated that knockdown of Aurora‑A in GBM cells enhances TMZ sensitivity in vitro and in vivo. Therefore, Aurora‑A knockdown may be a novel treatment option for decreasing TMZ toxicity and improving patient quality of life.
View Figures
View References

Related Articles

Journal Cover

December-2016
Volume 12 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Gan J, Wang F, Mu D, Qu Y, Luo R and Wang Q: RNA interference targeting Aurora-A sensitizes glioblastoma cells to temozolomide chemotherapy. Oncol Lett 12: 4515-4523, 2016.
APA
Gan, J., Wang, F., Mu, D., Qu, Y., Luo, R., & Wang, Q. (2016). RNA interference targeting Aurora-A sensitizes glioblastoma cells to temozolomide chemotherapy. Oncology Letters, 12, 4515-4523. https://doi.org/10.3892/ol.2016.5261
MLA
Gan, J., Wang, F., Mu, D., Qu, Y., Luo, R., Wang, Q."RNA interference targeting Aurora-A sensitizes glioblastoma cells to temozolomide chemotherapy". Oncology Letters 12.6 (2016): 4515-4523.
Chicago
Gan, J., Wang, F., Mu, D., Qu, Y., Luo, R., Wang, Q."RNA interference targeting Aurora-A sensitizes glioblastoma cells to temozolomide chemotherapy". Oncology Letters 12, no. 6 (2016): 4515-4523. https://doi.org/10.3892/ol.2016.5261